publication date: Mar. 15, 2019

In Brief

Fred Hirsch to join Mount Sinai Tisch Cancer Institute

Fred Hirsch has joined Mount Sinai Health System as executive director of the newly-created Center for Thoracic Oncology in The Tisch Cancer Institute at Mount Sinai.

Hirsch was also named the Richard Stein, Joe Lowe, and Louis Price Professor of Medicine at the Icahn School of Medicine at Mount Sinai. He will serve as the associate director of biomarker discovery for The Tisch Cancer Institute.

Hirsch’s research has helped identify and validate prognostic markers for lung cancer outcomes and biomarkers for personalized lung cancer therapies that illustrate how these therapies work and who is most likely to benefit from them.

The center will expand Mount Sinai’s lung cancer screening program. Patients will also have access to the latest research and clinical trials.

Hirsch comes to Mount Sinai from the University of Colorado School of Medicine in Denver, where he was the associate director for the University of Colorado Cancer Center and a professor of medicine and pathology.

While there, Hirsch was the CEO of the International Association for the Study of Lung Cancer, a global organization dedicated solely to the study of lung cancer and other thoracic malignancies.


Reps. Higgins, Guthrie, Matsui and Bilirakis announce the Cancer Drug Parity Act

Reps. Brian Higgins (D–NY), Brett Guthrie (R–KY), Doris Matsui (D–CA), and Gus Bilirakis (R–FL) announced introduction of the Cancer Drug Parity Act, a bipartisan bill requiring health insurance plans that cover intravenous and injectable cancer medications to also cover orally administered cancer medications at the equivalent rate.

“Innovative research has led to more effective and accessible treatment options for … Continue reading Fred Hirsch to join Mount Sinai Tisch Cancer Institute

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.